Who invested in Beacon Biosignals?
Beacon Biosignals's investors include Alumni Ventures, General Catalyst, Catalio Capital Management, FJ Labs and 8VC, and 5 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$97Mraised across 2 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $103M sold
Source recorded and 1 otherSEC filing: $24M sold, first sale Jul 2025
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Beacon Biosignals's investors include Alumni Ventures, General Catalyst, Catalio Capital Management, FJ Labs and 8VC, and 5 more on record.
Beacon Biosignals has raised $97M across 2 rounds since 2025.
Beacon Biosignals's most recent round was a Series B of $11M in Apr 2026.
Beacon Biosignals's largest round on record is $86M (Series B), in Nov 2025.
Beacon Biosignals's first round on record, in Nov 2025, was backed by Alumni Ventures, General Catalyst and FJ Labs and 6 others.
Beacon Biosignals's latest named round is a Series B, in Apr 2026.
Beacon Biosignals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.